Country-specific benefit-cost ratios.

1

Financial cost does not include the cost of ivermectin and albendazole, which are both donated. DEC must be purchased by national programs and is therefore included as a financial cost. Ivermectin is used in combination with albendazole in areas co-endemic for onchocerciasis in Africa plus Yemen. DEC, which is not donated, is used in combination with albendazole in all other countries and must be purchased by national programs.

2

Economic cost includes the implied cost of donated materials and drugs (Source: Goldman et al. (2007) [54]): US$0.19+$0.0019 for shipping per 400mg tablet of albendazole and US$1.50+$0.0018 per 3mg tablet of ivermectin.

3

Includes both individual and health system benefits. Currency is adjusted to match year of MDA round.

4

Source: Goldman et al. (2007) [54].

*Countries receiving the albendazole+ivermectin drug regimen.